Our research projects

Type 2 diabetes can come with an increased risk of cardiovascular problems affecting the heart and blood vessels. Professor Stephen Wheatcroft wants to test ‘recipes’ for new molecules that can protect against these issues, and also treat type 2 diabetes. This could help researchers to develop new treatments for type 2 diabetes that also lower the risk of cardiovascular disease.

Established in 2011, ADDRESS-2 is a database of information from of people newly diagnosed with type 1 diabetes who have agreed to be involved in research. This new funding will continue to support the program and allow the team recruit more people. The team will work with the type 1 diabetes Immunotherapy Consortium to increase the number of people recruited into immunotherapy trials. These trials aim to find new ways to prevent, or cure, type 1 diabetes.

Diabetic foot ulcers can have a huge impact on people’s lives, and, in the most serious cases, infections can put people at risk of life-altering amputations. Dr Wilkinson wants to understand how bacteria cause infections and slow healing in foot ulcers in people with type 2 diabetes. This will help to develop new treatments that could protect people with diabetes against amputations.

Cilia are tiny, hair-like structures that help cells communicate. Dr Nalia Haq is studying whether cilia problems in insulin-making beta cells contribute to the development of type 1 diabetes,  or result from it. Her findings could help us better understand the root causes of type 1 diabetes, and point to targets for new treatments to slow or prevent it.

Living with diabetes can increase the risk of kidney disease, which in turn increases the risk of heart disease. Professor Luigi Gnudi has found a new protein that can tune signalling molecules to protect kidney cells and blood vessels. Understanding how the protein does this could help researchers to develop new treatments that can heal damaged kidney cells and also lower the risk of heart and blood vessel problems for people living with diabetes. 

Some people with diabetes go on to develop problems with the nerves in their feet. This is known as peripheral neuropathy and can affect safe driving. Professor Marple-Horvat is investigating if a driving stimulator and feedback system can help people with peripheral neuropathy get back to driving safely again, and keep their independence.

Many people who use metformin to manage their type 2 diabetes, often need to start on a second medication to control blood sugar levels. Dr Beall wants to better understand the effect of metformin in the brain and why this may cause some people with type 2 to stop responding to it over time. He’ll also shed new light on if and how metformin may have anti-inflammatory effects in the brain. In the future this could help us to understand who is more likely to need an add on treatment and open-up new ways to keep the brain healthy in people with diabetes. 

Diabetes can cause many complications including foot ulcers. These can lead to a significantly higher risk of heart attacks, strokes and a shortened lifespan. Professor Khunti and his team are researching the best way to reduce these so that people with diabetes and foot ulcers can have healthier and longer lives. 

Some people with type 2 diabetes might have differences in how their brains get messages about sweet flavours. Dr Sally Eldeghaidy wants to find out more about why this is, by looking for signals in brain scans. Her project could lead to a better understanding about how sweet things taste to people with type 2, and make it easier for them to choose healthier food and increase their chance of putting their type 2 diabetes into remission.

People living with diabetes are invited to attend routine eye screening appointments to protect their eye health. However, eye drops used during these visits can be uncomfortable and irritating and put people off attending. Professor Scanlon is testing whether a new camera can avoid the need for eye drops in Asian and African-Caribbean people. This research could protect more people from different ethnicities against diabetes-related eye damage.